A Six-Hour Interprofessional Symposium
Sunday, October 10, 2021
8:45 am – 4:30 pm (EST)
Cost:
- No out-of-pocket cost for eligible 1199SEIU members
- All other participants: $150
Live Webcast (Internet)
The deadline to register for this event is Friday, October 8, 2021, 12:00 pm (EDT).
Program Moderator:
Arnold Markowitz, MD
Director, Gastroenterology Fellowship Training Program, Memorial Sloan-Kettering Cancer Center, New York, NY.
Program and Learning Objectives
8:45 am — Login
9:20 am — Welcome and Introductory Remarks
9:30 am — Colon Cancer: Overview of Incidence Patterns, Risk Factors and Prevention
Presenter:
Arnold Markowitz, MD
Descriptive Summary:
Colon cancer develops in the colon or rectum, which are both segments of the large intestine, and is often referred to as colorectal cancer. It is one of the most common forms of cancer for both men and women in the United States, with an estimated 149,500 new cases diagnosed and 52,980 deaths occurring from the disease in 2021. At the same time, surveillance strategies can help prevent the development of colon cancer.
Learning Objectives:
Upon completion, participants will be able to:
- Outline the anatomy of the large intestine;
- Understand the impact of colon cancer in the U.S., including the risk of developing and dying from the disease;
- Recognize potential signs and symptoms of colon cancer;
- Discuss hereditary factors and syndromes associated with colon cancer;
- Review how colon cancer develops;
- Describe screening tests and surveillance strategies for colon cancer prevention;
- Become knowledgeable about the clinical evaluation and staging of colon cancer; and
- Explain indications and options for surgery, as well as chemotherapy and radiation.
10:30 am — The Role of Pathology in Colon Cancer Screening and Diagnosis
Presenter:
Efsevia (Evi) Vakiani MD, PhD
Descriptive Summary:
Colorectal cancer is the third most common cancer in the United States and the third leading cause of cancer-related deaths. Pathologists play a critical role in its diagnosis and treatment. They provide accurate histologic diagnosis of polyps removed during screening colonoscopy guiding subsequent steps in clinical management. They assess pathologic staging of resection specimens including evaluation of surgical margins and presence of prognostic parameters such as lymphovascular invasion, which determine adjuvant chemotherapy. Pathologists also play a central role in screening for carcinomas that show microsatellite instability (MSI), which is important in identifying families with hereditary non-polyposis syndrome as well as tumors that can benefit from immunotherapy. Molecular pathologists also evaluate tumors for MSI in addition to testing for alterations in genes such as KRAS and BRAF that impact response to targeted therapies.
Learning Objectives:
Upon completion, participants will be able to:
- Learn about different types of polyps that a gastroenterologist encounters during a screening colonoscopy and appreciate how precise diagnosis affects clinical care;
- Appreciate the process of accurately staging colorectal cancer resection specimens;
- Understand the importance of assessing tumors for microsatellite instability and familiarize themselves with the methods used by pathologists towards that goal; and
- Recognize the role of the molecular pathologist in guiding targeted therapy of colorectal cancer.
11:30 am — Colon Cancer Radiation Oncology and Treatment: Invasive vs. Non-Invasive Approach
Presenter:
Viktoriya Paroder, MD, PhD
Descriptive Summary:
Ongoing advancements in screening and treatments for colorectal cancer, including surgery and chemotherapy, continue to lead to significant improvements in diagnosis, treatment and survival. At the same time, advancements in imaging have expanded the role of radiologists at all stages of the disease management process, from pre-treatment evaluation and staging to post-operative and post-treatment management and surveillance. This presentation will cover the roles of different modalities, including computed tomography (CT) scans, magnetic resonance imaging (MRI), abdominal ultrasounds, endorectal ultrasounds (ERUS) and positron emission tomography (PET) in the current approach to colorectal cancer management.
Learning Objectives:
Upon completion, participants will be able to:
- Discuss the imaging modalities used for colorectal cancer diagnosis, treatment and follow-up;
- Describe the basic principles of staging colorectal cancer;
- Explain how imaging contributes to treatment planning and follow-up;
- Understand how imaging is used for surveillance; and
- Discuss the challenges associated with imaging.
12:30 am — Lunch Break
1:30 pm — Pharmacological Management of Colon Cancer
Presenter:
Sara Kim, PharmD
Descriptive Summary:
Colon cancer has shown to be a highly heterogeneous disease with considerable variation in genomics, molecular biomarkers and tumor microenvironment. This presentation will discuss the management of colon cancer and the personalized approach of integrating targeted therapy and immunotherapy for emerging immune tumor biomarkers in metastatic disease. Toxicity profiles of targeted therapy and immunotherapy will be compared to conventional chemotherapy.
Learning Objectives:
Upon completion, participants will be able to:
- Review current treatment strategies of colon cancer;
- Identify actionable molecular biomarkers and describe the integration of targeted therapies into colon cancer management; and
- Describe notable toxicities associated with conventional and targeted immunotherapy and discuss management strategies.
2:30 pm — Nutritional Management of the Colon Cancer Patient
Presenter:
Marissa May, MS, RD
Descriptive Summary:
Nutrition and lifestyle play both a preventive and causal role in colorectal cancer. Eating a healthful diet and engaging in physical activity may help protect against developing the disease, while poor diet and certain lifestyle choices may contribute to an increased risk. This presentation will discuss dietary recommendations for the prevention, treatment and survivorship of colorectal cancer.
Learning Objectives:
Upon completion, participants will be able to:
- Discuss dietary and lifestyle recommendations for the prevention of colon cancer;
- Understand the goals of nutrition therapy during cancer treatment; and
- Specify dietary measures that will help patients manage their disease, as well as the impact of treatment.
3:30 pm — Psychosocial Support in Colon Cancer: Community, Family, and Patient
Presenter:
Alison Snow, PhD, LCSW-R, OSW-C
Descriptive Summary:
Psychosocial services are essential for comprehensive cancer care and are provided to cancer patients and their caregivers throughout the continuum of care. These services address physical, psychological, social, emotional, spiritual and financial needs that result from a cancer diagnosis. Colon cancer survivors can experience a number of psychosocial issues, such as cancer-related distress, adjustment to physical changes following treatment and fear of cancer recurrence. This presentation will review social work interventions, community resources for colon cancer patients and general oncology support resources.
Learning Objectives:
Upon completion, participants will be able to:
- Summarize the psychosocial issues surrounding colon cancer diagnosis, treatment and survivorship;
- Describe psychosocial interventions for colon cancer patients and evaluate the current science; and
- Explore resources in the community for psychosocial support.
4:30 pm — Participants submit online evaluations
Accreditation
CASACs:
An application has been submitted to the New York State Office of Alcoholism and Substance Abuse Services for six (6) clock hours.
Clinical Laboratory Practitioners:
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology (ASCP) for six (6) CMLE credits. ASCP CMLE credits are acceptable for the ASCP Board of Registry Certification Maintenance Program.
Dietitians/Dietetic Technicians:
An application has been submitted to the Commission for Dietetic Registration (CDR) for six (6) continuing education units.
Imaging Technologists:
This course is approved by the American Society of Radiologic Technologists (ASRT) for seven (7) Category A continuing education credits. The American Registry for Diagnostic Medical Sonography (ARDMS) accepts ASRT Category A credits.
LPNs/RNs/Nurse Practitioners:
This course is approved by the California Board of Registered Nursing for six (6) continuing education credits.
Medical Records Coders:
This course is approved by the American Health Information Management Association (AHIMA) for six (6) continuing education credits.
Occupational Therapists/Occupational Therapy Assistants:
This course is approved by the New York State Occupational Therapy Association, Inc. (NYSOTA) for six (6) contact hours (NY licensees only).
Paramedics/EMTs:
An application has been submitted to the Regional Emergency Medical Services Council of New York City for EMS CME credits.
Pharmacists and Pharmacy Technicians:
The New York State Council of Health-system Pharmacists (NYSCHP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
- Module A (AM): This course, 0134-0000-21-159-L01-P; 0134-0000-21-159-L01-T, is approved for 0.3 CEUs (3 contact hours).
- Module B (PM): This course, 0134-0000-21-160-L01-P; 0134-0000-21-160-L01-T, is approved for 0.3 CEUs (3 contact hours).
Statements of Continuing Pharmacy Education Credit are available to participants upon the conclusion of the program through survey links. Participants have 45 days from date of program to claim credits and must verify attendance at the meeting by entering the program CE code.
Physical Therapists/Physical Therapy Assistants:
This course is approved by the New York Physical Therapy Association (NYPTA) for 7.2 contact hours (NY licensees only).
Physician Assistants:
This course is approved by the Physician Assistant Review Panel for six (6) AAPA Category 1 CME credits.
Respiratory Therapists:
An application has been submitted to the American Association for Respiratory Care (AARC) for six and one half (6.5) continuing education credits.
Social Workers:
The 1199SEIU League Training and Upgrading Fund SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers under provider #0286. Licensed NYS Social Workers are required to provide NYS license number to receive certificate of credit. This course is approved for six (6) continuing education hours.
All Other Healthcare Professionals:
Will receive a general certificate of attendance. Please check with your accreditation board with respect to receiving credit for this program.
Presenters:
Arnold Markowitz, MD
Director, Gastroenterology Fellowship Training Program, Memorial Sloan-Kettering Cancer Center, New York, NY.
Efsevia (Evi) Vakiani MD, PhD
Associate Attending Pathologist, Memorial Sloan-Kettering Cancer Center, New York, NY.
Viktoriya Paroder, MD, PhD
Radiologist, Memorial Sloan-Kettering Cancer Center, New York, NY
Sara Kim, PharmD
Senior Oncology Clinical Pharmacy Specialist, Northwell Health Cancer Institute, Lake Success, NY.
Marissa May, MS, RD
Clinical Dietitian, Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL.
Alison Snow, PhD, LCSW-R, OSW-C
Director, Cancer Supportive Services, Mount Sinai Downtown Cancer Centers; Assistant Professor, Hematology and Medical Oncology and Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, New York, NY.
Eligibility for 1199SEIU Members
Training and Employment Fund Members
To be eligible to attend this seminar at no cost, 1199SEIU members must have been a part-time or full-time employee for at least one year and work at least three-fifths of a regular workweek and work for an employer who contributes to the 1199SEIU Training and Upgrading Fund or the 1199SEIU Greater New York Education Fund.
City of New York Education, Child and Eldercare Fund Members
Pharmacists, Dietitians, Clinical Laboratory Practitioners and LPNs are all eligible. You must have worked with New York Health + Hospitals or a mayoral agency for at least one year.
For Further Information
Email: [email protected]
Refund and Cancellation Policy
Registrants canceling must do so at least 48 hours before the program date to avoid a penalty. To cancel, contact the 1199SEIU League Training and Upgrading Fund (TUF) by fax (212) 643-8795, telephone (212) 894-4390 or e-mail [email protected]. TUF reserves the right to cancel or reschedule a program in the event of insufficient enrollment or unforeseen circumstances. Participants will be notified and given the option of a refund, or to attend the rescheduled program or an alternate program.